RMD News: Q2 2024 Resmed Inc Earnings Call - 26th Jan 2024, 4:38am

[annb0t]

Participants

Amy Wakeham; Chief IR Officer; ResMed Inc.

Brett A. Sandercock; CFO; ResMed Inc.

Michael J. Farrell; CEO & Chairman; ResMed Inc.

Anthony Charles Petrone; MD & Senior Medical Devices, Diagnostics and Therapeutics Equity Research Analyst; Mizuho Securities USA LLC, Research Division

Lyanne Harrison; VP in Global Equity Research; BofA Securities, Research Division

Malgorzata Maria Kaczor Andrew; Partner & Research Analyst; William Blair & Company L.L.C., Research Division

Mathie...

>>> Read more: Q2 2024 Resmed Inc Earnings Call